FDA Enforcement Class II Terminated

FHC Guideline 4000 5.0 GL5 Main Processing Unit - Product Usage: intended to record and stimulate electrophysiological activity, as well as aid in the accurate placement of electrodes and other instruments. Catalogue Number: C0215 UDI: 00873263006740

Recall: Z-2540-2020 · Reported July 15, 2020

Enforcement

Recall Number
Z-2540-2020
Event ID
85897
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
FHC, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
July 15, 2020
Initiation Date
June 17, 2020
Classification Date
July 8, 2020
Termination Date
November 2, 2020
Address
1201 Main St, Bowdoin, ME, 04287-7302, United States

Description

FHC Guideline 4000 5.0 GL5 Main Processing Unit - Product Usage: intended to record and stimulate electrophysiological activity, as well as aid in the accurate placement of electrodes and other instruments. Catalogue Number: C0215 UDI: 00873263006740

Reason

An electrical sub-circuit was not properly connected. Its purpose is to eliminate the possibility of interference with proper performance of the Guideline 5 Main Processing Unit, if an ESD event (greater than 6kV) were to occur.

Code Info

Serial Numbers: 45695, 48871, 48873, 48874, 46195, 46198

Distribution

US Nationwide distribution including in the states of CA, NC, TN, TX, WA.

Quantity

6 units